CUFinder

Greg Delgoffe

Greg Delgoffe

University of Pittsburgh

H-index: 43

North America-United States

Contact Greg Delgoffe

About Greg Delgoffe

Greg Delgoffe, With an exceptional h-index of 43 and a recent h-index of 39 (since 2020), a distinguished researcher at University of Pittsburgh, specializes in the field of immunology, metabolism, cancer, immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance

Metabolic waypoints during T cell differentiation

Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection

Antiviral epithelial-macrophage crosstalk permits secondary bacterial infections

Integrating innate and adaptive immunity in oncolytic virus therapy

An oncolytic virus–delivered tgfβ Inhibitor overcomes the immunosuppressive tumor microenvironment

Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study

The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck

Greg Delgoffe Information

University

Position

Associate Professor of Immunology

Citations(all)

12732

Citations(since 2020)

8793

Cited By

6845

hIndex(all)

43

hIndex(since 2020)

39

i10Index(all)

60

i10Index(since 2020)

60

Email

University Profile Page

Google Scholar

Greg Delgoffe Skills & Research Interests

immunology

metabolism

cancer

immunotherapy

Top articles of Greg Delgoffe

An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance

Cancer Immunology Research

2024/4/11

Lulu Shao
Lulu Shao

H-Index: 11

Rashmi Srivastava
Rashmi Srivastava

H-Index: 3

Saumendra N Sarkar
Saumendra N Sarkar

H-Index: 26

Metabolic waypoints during T cell differentiation

2024/1/18

Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection

PLoS pathogens

2023/11/8

Antiviral epithelial-macrophage crosstalk permits secondary bacterial infections

Mbio

2023/10/31

Integrating innate and adaptive immunity in oncolytic virus therapy

2023/10/23

An oncolytic virus–delivered tgfβ Inhibitor overcomes the immunosuppressive tumor microenvironment

Journal of Experimental Medicine

2023/8/8

Konstantinos Lontos
Konstantinos Lontos

H-Index: 5

Lukasz Wieteska
Lukasz Wieteska

H-Index: 11

Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study

Frontiers in Oncology

2023/6/16

Ziyu Huang
Ziyu Huang

H-Index: 0

Fei Ding
Fei Ding

H-Index: 1

Diwakar Davar
Diwakar Davar

H-Index: 17

The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck

Oral Oncology

2023/5/1

The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy

JCI insight

2023/2/2

Jina Chang
Jina Chang

H-Index: 3

Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity

Nature immunology

2023/2

Konstantinos Lontos
Konstantinos Lontos

H-Index: 5

Obesity is associated with altered tumor metabolism in metastatic melanoma

Clinical Cancer Research

2023/1/4

Jun Li
Jun Li

H-Index: 16

Xiaogang Wu
Xiaogang Wu

H-Index: 4

Jian Wang
Jian Wang

H-Index: 13

Han Liang
Han Liang

H-Index: 4

Jianhua Zhang
Jianhua Zhang

H-Index: 22

Weiyi Peng
Weiyi Peng

H-Index: 22

Excess dietary sugar alters colonocyte metabolism and impairs the proliferative response to damage

Cellular and molecular gastroenterology and hepatology

2023/1/1

Junyi Ji
Junyi Ji

H-Index: 1

Xiaoyi Zhang
Xiaoyi Zhang

H-Index: 5

Abigail Overacre-Delgoffe
Abigail Overacre-Delgoffe

H-Index: 8

Semir Beyaz
Semir Beyaz

H-Index: 13

Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors

Journal for Immunotherapy of Cancer

2023

Konstantinos Lontos
Konstantinos Lontos

H-Index: 5

Yiyang Wang
Yiyang Wang

H-Index: 3

Alok Kumar
Alok Kumar

H-Index: 19

Jason Lohmueller
Jason Lohmueller

H-Index: 11

Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors

Oncoimmunology

2023/12/31

Jian Ding
Jian Ding

H-Index: 23

Guangwu Guo
Guangwu Guo

H-Index: 23

Greg Delgoffe
Greg Delgoffe

H-Index: 29

Redox and detox: Malate shuttle metabolism keeps exhausted T cells fit

Cell Metabolism

2023/12/5

Alok Kumar
Alok Kumar

H-Index: 19

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology

OncoImmunology

2022/12/31

Konstantinos Lontos
Konstantinos Lontos

H-Index: 5

Yiyang Wang
Yiyang Wang

H-Index: 3

Alok Kumar
Alok Kumar

H-Index: 19

Jason Lohmueller
Jason Lohmueller

H-Index: 11

Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression

Cell reports

2022/9/20

Yiyang Wang
Yiyang Wang

H-Index: 3

Anna Bostwick
Anna Bostwick

H-Index: 2

Yi-Nan Gong
Yi-Nan Gong

H-Index: 12

Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells

Science immunology

2022/8/5

Konstantinos Lontos
Konstantinos Lontos

H-Index: 5

Fungal sensing enhances neutrophil metabolic fitness by regulating antifungal Glut1 activity

Cell host & microbe

2022/4/13

De-Dong Li
De-Dong Li

H-Index: 12

Li Lin
Li Lin

H-Index: 11

Jishnu Das
Jishnu Das

H-Index: 18

Hypoxia reduction sensitizes refractory cancers to immunotherapy

2022/1/27

See List of Professors in Greg Delgoffe University(University of Pittsburgh)